Grantham, Mayo, Van Otterloo & Co (GMO)’s Brink's BCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,300
Closed -$200K 719
2022
Q2
$200K Buy
+3,300
New +$199K ﹤0.01% 714

Other funds holding BCO

Grantham, Mayo, Van Otterloo & Co (GMO)'s BCO Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Brink's (BCO) in Q3 2022, closing a stake of 3,300 shares — an estimated $200K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCO in Q2 2022 and held it in 1 quarter. The position peaked at $200K in Q2 2022. 212 funds tracked by Wall St. Rank hold BCO as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Brink's position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,300 Brink's shares in Q3 2022, an estimated $200K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Brink's in Q2 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Brink's position peaked at $200K in Q2 2022.
  • 212 funds tracked by Wall St. Rank held Brink's as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.